title: Relaxin-2 may offer therapeutic advantages in end-stage heart failure.
authors.forename: Zhiqiang
authors.initials: Z
authors.lastname: Zhao
authors.forename: Tong
authors.initials: T
authors.lastname: Liu
authors.forename: Guangping
authors.initials: G
authors.lastname: Li
mesh_terms: D002908:Chronic Disease; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D012065:Relaxin / Q000378:metabolism / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: C095068:RLN2 protein, human; D014665:Vasodilator Agents; D012065:Relaxin